The research board and its decisions

All projects performed on LBIC´s preclinical imaging platforms are evaluated before acceptance with respect to possibility to perform the intended experiments successfully, given the available equipment at LBIC. This evaluation is performed by the LBIC preclinical research board (RB). Please note that in the application the intended experiments should be described in their biological or medical context to facilitate the evaluation of the research board. The description should aim at showing that the intended in vivo or in vitro experiments are possible to realize.

Present members of the RB are:
Research Board chair: Ritha Gidlöf, PhD;  
Research Board Members: Sebastian Wasserstrom, PhD; Michael Gottschalk, PhD; Katarina Sjögren-Gleisner, Prof.; Thomas Blom, PhD.

The RB meets bimonthly to monthly. Please note that a particular experiment may require repeated handling from the RB. As a general rule the RB, or the relevant platform responsible on request from the RB, will communicate with the PI already during project planning in order to estimate e.g. the need for scanner time and LBIC support (see below) in the experimental phase. If external PIs are in need of a parallel ethics permission for animal handling when imaging is performed at LBIC, LBIC may be able to give support after evaluation on a case-by-case basis. The PI should inform the RB about such needs as soon as possible in the application procedure.